Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neumora Therapeutics, Inc. | 80,000 | reported | 27 May 2026 | tx 13+405,178−150,052 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Neumora Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 46,455 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 46,455 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 46,455 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 28,571 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 46,455 | — | deriv |
| 13 Jun 2024 | GRANT_AWARD | Neumora Therapeutics, Inc. | 20,100 | 0.00 USD | |
| 13 Jun 2024 | GRANT_AWARD | Neumora Therapeutics, Inc. | 28,571 | 0.00 USD | deriv |
| 14 Sept 2023 | GRANT_AWARD | Neumora Therapeutics, Inc. | 46,455 | 0.00 USD | deriv |